Cite
Development of Leishmania donovani stably expressing DsRed for flow cytometry-based drug screening using chalcone thiazolyl-hydrazone as a new antileishmanial target.
MLA
Jaiswal, Anil Kumar, et al. “Development of Leishmania Donovani Stably Expressing DsRed for Flow Cytometry-Based Drug Screening Using Chalcone Thiazolyl-Hydrazone as a New Antileishmanial Target.” International Journal of Antimicrobial Agents, vol. 48, no. 6, Dec. 2016, pp. 695–702. EBSCOhost, https://doi.org/10.1016/j.ijantimicag.2016.09.018.
APA
Jaiswal, A. K., Rao, K. B., Kushwaha, P., Rawat, K., Modukuri, R. K., Khare, P., Joshi, S., Mishra, S., Rai, A., Sashidhara, K. V., & Dube, A. (2016). Development of Leishmania donovani stably expressing DsRed for flow cytometry-based drug screening using chalcone thiazolyl-hydrazone as a new antileishmanial target. International Journal of Antimicrobial Agents, 48(6), 695–702. https://doi.org/10.1016/j.ijantimicag.2016.09.018
Chicago
Jaiswal, Anil Kumar, K. Bhaskara Rao, Pragati Kushwaha, Keerti Rawat, Ram K. Modukuri, Prashant Khare, Sumit Joshi, et al. 2016. “Development of Leishmania Donovani Stably Expressing DsRed for Flow Cytometry-Based Drug Screening Using Chalcone Thiazolyl-Hydrazone as a New Antileishmanial Target.” International Journal of Antimicrobial Agents 48 (6): 695–702. doi:10.1016/j.ijantimicag.2016.09.018.